Core Viewpoint - Driven Brands Holdings Inc. is under investigation for potential claims due to significant financial reporting errors that led to a 30% drop in its stock price [1] Financial Reporting Issues - Driven Brands delayed its fourth-quarter release due to material errors in financial statements for fiscal years 2023 and 2024 [1] - The company disclosed that its previously issued financial statements should not be relied upon and require restatement [1] - Errors identified include lease recording issues affecting right of use assets and liabilities, cash account discrepancies leading to overstatements of cash and revenue, and overstated company-operated store expenses [1] Internal Control Weaknesses - Driven Brands identified material weaknesses in internal control over financial reporting [1] - The Report of its Independent Registered Public Accounting Firm on the financial statements and internal control should not be relied upon [1]

SAN DIEGO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Zynex, Inc. (OTCMKTS: ZYXIQ) securities between February 25, 2021 and December 15, 2025. Zynex is a medical device manufacturer that produces and markets electrotherapy devices for use in pain management, physical rehabilitation, neurological diagnosis, and cardiac monitoring. For more information, submit a form, email attorney Aaron Dumas ...

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed against Zynex, Inc. (OTCMKTS: ZYXIQ) (“Zynex” or the “Company”) inclusive on behalf of all persons and entities that purchased or otherwise acquired Zynex shares between February 25, 2021 and December 15, 2025, both dates inclusive (the "Class Period"). Investors have until April 21, 2026, to seek appointments as lead plaintiff. PLEASE CLICK HERE TO JOIN THE CASE AND SUB ...

Core Viewpoint - The article discusses a securities class action against Zynex, Inc. due to allegations of false and misleading statements regarding the company's business practices and financial reporting, with a deadline for investors to seek lead plaintiff status set for April 21, 2026 [1]. Group 1: Allegations Against Zynex - Zynex allegedly shipped products in excess of need, inflating its revenue [1][2] - The company faced scrutiny from insurers, including Tricare, for filing false claims [1][2] - A lawsuit was filed by Travelers against Zynex and its executives, seeking over $23 million in damages for fraudulent claims between 2018 and 2023 [1][2] - Management prioritized aggressive sales strategies over compliance with industry regulations [1][2] - The company was not committed to maintaining a strong internal control environment [1][2] - Order growth was attributed to illegal overbilling practices [1][2] - There is a reasonable likelihood of adverse consequences for Zynex, including removal from insurer networks and federal penalties [1][2] - Positive statements made by the defendants about the company's operations were materially misleading [1][2] Group 2: Financial Impact and Stock Performance - On March 11, 2025, Zynex reported a significant revenue shortfall due to slower payments from payers, leading to a stock price drop of $3.59 per share, or 51.3%, closing at $3.41 per share [1][2] - On July 31, 2025, Zynex acknowledged non-compliance with industry regulations, resulting in a stock decline from $2.23 per share to $1.26 per share, a 45% drop [1][2] Group 3: Legal Proceedings and Investor Actions - The court-appointed lead plaintiff will be the investor with the largest financial interest who directs the litigation on behalf of the class [1][2] - Any member of the class may move to serve as lead plaintiff or remain an absent class member without affecting their ability to share in any recovery [1][2] - Faruqi & Faruqi, LLP encourages individuals with information regarding Zynex's conduct to come forward [1][2]

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Zynex, Inc. (“Zynex” or the “Company”) (OTC: ZYXIQ) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join The Zynex Class Action Litigation? Do you, or did you, own shares of Zynex, Inc. (OTC: ZYXIQ)?Did you purchase your shares between February 25, 2021 and December 15, 2025, inclusive?Did you lose money in ...

Investor Notice: Robbins LLP Informs Investors of the Snowflake Inc. Class Action LawsuitFeb 25, 2026 2:44 PM Eastern Standard Time# Investor Notice: Robbins LLP Informs Investors of the Snowflake Inc. Class Action LawsuitShare---SAN DIEGO--([BUSINESS WIRE])-- [Robbins LLP] informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Snowflake Inc. (NYSE: SNOW) Class A common stock between June 27, 2023 and February 28, 2024. Snowflake is a software compa ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Zynex (ZYXIQ) To Contact Him Directly To Discuss Their Options If you purchased or acquired Zynex securities between February 25, 2021 to December 15, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- What’s Happening: Br ...

ATLANTA, Feb. 24, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Zynex, Inc. (“Zynex” or the “Company”) (OTCMKTS: ZYXIQ). The lawsuit alleges that Defendants issued false and misleading statements and/or failed to disclose material adverse facts regarding Zynex’s business, operations, and prospects, including allegations that: (1) Zynex shipped products, including electrodes, in excess of need; (2) as a result of this practice, the Company inflated its revenue; and (3) th ...

Core Viewpoint - A shareholder has filed a securities class action lawsuit against Zynex, Inc. for alleged misrepresentations regarding the company's revenue related to a fraudulent overbilling scheme from 2018 to 2023 [4]. Group 1: Lawsuit Details - The lawsuit represents investors who purchased or acquired Zynex securities between February 25, 2021, and December 15, 2025 [1]. - Defendants are accused of making false statements about the company's financial performance, specifically its reported revenue [4]. Group 2: Legal Process - Investors wishing to serve as lead plaintiffs must file necessary documents by April 21, 2026 [3]. - Participation as a lead plaintiff is not required to share in any potential recovery from the lawsuit [3]. Group 3: Firm Background - Bernstein Liebhard LLP, the law firm handling the case, has recovered over $3.5 billion for clients since its inception in 1993 [5]. - The firm has a strong reputation, being named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and recognized in The Legal 500 for sixteen consecutive years [5].

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Zynex, Inc. (OTCMKTS: ZYXIQ) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Zynex securities between February 25, 2021 and December 15, 2025, both dates ...